Therapy improves immunoregulatory responses in pemphigus vulgaris, suggesting new treatment avenues for this condition.
Journal Article Accepted manuscript Immunoregulatory effects of TPM203 peptide-nanoparticle therapy in pemphigus vulgaris Get access Chuda Rujitharanawong , Chuda Rujitharanawong Department of Dermatology, Columbia University, New York, NY, USADepartment of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Search for other works by this author on: Oxford Academic Google Scholar Aimee S Payne Aimee S Payne Department of Dermatology, Columbia University, New York, NY, USA Corresponding author: Aimee S. Payne, MD, PhD, Email:[email protected] Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, ljaf323, https://doi.org/10.1093/bjd/ljaf323 Published: 21 August 2025 Article history Received: 11 August 2025 Accepted: 12 August 2025 Published: 21 August 2025
No takes yet. Share an insight, caveat, or question.
Rujitharanawong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: